Glycoprotein A as a biomarker of pulmonary infection and inflammation in children with cystic fibrosis.

Although GlycA levels were higher on average in those who had an infection or neutrophilic inflammation, there was also considerable variability, limiting the clinical utility of this biomarker alone in determining early disease status in CF.